| Mathematical modeling of HIV prevention measures including pre-exposure prophylaxis on HIV incidence in South Korea SB Kim, M Yoon, NS Ku, MH Kim, JE Song, JY Ahn, SJ Jeong, C Kim, ... PloS one 9 (3), e90080, 2014 | 49 | 2014 |
| Role of seminal shedding of herpesviruses in HIV type 1 transmission S Gianella, SR Morris, MV Vargas, JA Young, B Callahan, DD Richman, ... The Journal of infectious diseases 207 (2), 257-261, 2013 | 49 | 2013 |
| Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses W He, R Musharrafieh, G Song, K Dueker, LV Tse, DR Martinez, ... Nature immunology 23 (6), 960-970, 2022 | 48 | 2022 |
| Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies JZ Li, E Aga, RJ Bosch, M Pilkinton, E Kroon, L MacLaren, M Keefer, ... Clinical Infectious Diseases 74 (5), 865-870, 2022 | 48 | 2022 |
| The prostate as a reservoir for HIV-1 DM Smith, JD Kingery, JK Wong, CC Ignacio, DD Richman, SJ Little Aids 18 (11), 1600-1602, 2004 | 48 | 2004 |
| Spread of misinformation about face masks and COVID-19 by automated software on Facebook JW Ayers, B Chu, Z Zhu, EC Leas, DM Smith, M Dredze, DA Broniatowski JAMA internal Medicine 181 (9), 1251-1253, 2021 | 47 | 2021 |
| Next generation sequencing improves detection of drug resistance mutations in infants after PMTCT failure RG Fisher, DM Smith, B Murrell, R Slabbert, BM Kirby, C Edson, ... J Clin Virol 62, 48-53, 0 | 47* | |
| Evaluating Artificial Intelligence Responses to Public Health Questions JW Ayers, Z Zhu, A Poliak, EC Leas, M Dredze, M Hogarth, DM Smith JAMA Network Open 6 (6), e2317517-e2317517, 2023 | 46 | 2023 |
| Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance S Chaturvedi, G Vasen, M Pablo, X Chen, N Beutler, A Kumar, E Tanner, ... Cell 184 (25), 6022-6036. e18, 2021 | 46 | 2021 |
| No evidence of SARS-CoV-2 seminal shedding despite SARS-CoV-2 persistence in the upper respiratory tract SA Rawlings, C Ignacio, M Porrachia, P Du, DM Smith, A Chaillon Open Forum Infectious Diseases 7 (8), ofaa325, 2020 | 46 | 2020 |
| Compartmentalized HIV rebound in the central nervous system after interruption of antiretroviral therapy S Gianella, SL Kosakovsky Pond, MF Oliveira, K Scheffler, MC Strain, ... Virus evolution 2 (2), vew020, 2016 | 46 | 2016 |
| Self-reported Cannabidiol (CBD) Use for Conditions With Proven Therapies EC Leas, EM Hendrickson, AL Nobles, R Todd, DM Smith, M Dredze, ... JAMA network open 3 (10), e2020977-e2020977, 2020 | 44 | 2020 |
| Temporal variation in HIV-specific IgG subclass antibodies during acute infection differentiates spontaneous controllers from chronic progressors S Sadanand, J Das, AW Chung, MK Schoen, S Lane, TJ Suscovich, ... Aids 32 (4), 443-450, 2018 | 44 | 2018 |
| The use of pooled viral load testing to identify antiretroviral treatment failure DM Smith, SJ May, J Pérez-Santiago, MC Strain, CC Ignacio, ... Aids 23 (16), 2151-2158, 2009 | 44 | 2009 |
| Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection R Deo, MC Choudhary, C Moser, J Ritz, ES Daar, DA Wohl, AL Greninger, ... Annals of Internal Medicine 176 (3), 348-354, 2023 | 43* | 2023 |
| Risk of New-Onset Type 2 Diabetes Mellitus in 600,055 Persons after COVID-19: a cohort study M Birabaharan, DC Kaelber, JH Pettus, DM Smith Diabetes, obesity & metabolism 24 (6), 1176, 2022 | 43 | 2022 |
| AI-guided discovery of the invariant host response to viral pandemics D Sahoo, GD Katkar, S Khandelwal, M Behroozikhah, A Claire, V Castillo, ... EBioMedicine 68, 2021 | 43 | 2021 |
| Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries … MW Tang, SY Rhee, S Bertagnolio, N Ford, S Holmes, KC Sigaloff, ... The Journal of infectious diseases 207 (suppl_2), S70-S77, 2013 | 43 | 2013 |
| An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China Y Zhang, L Qiao, W Ding, F Wei, Q Zhao, X Wang, Y Shi, N Li, D Smith, ... Journal of neurovirology 18, 120-126, 2012 | 43 | 2012 |
| Viral pneumonia as a serious complication of etanercept therapy D Smith, S Letendre Annals of internal medicine 136 (2), 174, 2002 | 43 | 2002 |
